Hong Kong imitates US IPO market but China is its real competition - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号)。如果该手机号尚未注册,将自动创建 FT中文网账号。短信可能需要几分钟送达,验证码15分钟内有效,请耐心等待:
请您阅读我们的用户注册协议和隐私权保护政策,点击下方按钮即视为您接受。
港交所

Hong Kong imitates US IPO market but China is its real competition

Allowing all companies to file confidentially for an initial public offering looks fruitless
00:00

{"text":[[{"start":5.14,"text":"Hong Kong is not the first stock exchange to eye rule changes to make it look more like the US. But its latest move — allowing all companies to file confidentially for an initial public offering — looks particularly fruitless. While the Asian hub measures itself against New York, it’s Shanghai and Shenzhen that are its real competition."}],[{"start":24.3,"text":"On Friday, the city’s market operator said it would let IPO candidates file prospectuses behind closed doors, meaning any adjustments requested by the regulator happen before the public gets a look. Previously, only certain high-growth tech and biotechnology groups enjoyed that privilege. Now, so will any companies joining the 534 in Hong Kong’s official IPO queue."}],[{"start":47.08,"text":"Filing in public can bring some uncomfortable rough and tumble. In the US, shoemaker Allbirds was forced by the Securities and Exchange Commission to remove its claim to be the world’s first sustainable IPO in 2021. That said, investors may be better off for the insights into a company’s culture that such changes convey."}],[{"start":66.12,"text":"The chances are, though, that most companies will take HKEX up on its offer. About two-fifths of those in the current queue have not filed publicly. The US has offered confidential filing for growth companies since 2012 and for almost everyone since 2017. SpaceX and Anthropic are recent beneficiaries."}],[{"start":null,"text":"

Column chart of Initial public offering proceeds by listing market ($bn) showing Bourse race
"}],[{"start":86.16,"text":"Hong Kong’s case for enabling companies to avoid early limelight is that it competes against New York. But it’s an unequal competition. Hong Kong’s best-known international trophy listings — L’Occitane, Samsonite and Prada — date from 15 years ago. The first of the trio since went private; the others have discussed dual listings elsewhere."}],[{"start":105.52,"text":"The reality is that more than four-fifths of Hong Kong’s IPO proceeds over the past 20 years have been raised by mainland Chinese companies, according to Dealogic data. For many Chinese entrepreneurs, politics means a US stock code isn’t on the cards. Since Chinese ride-hailing app DiDi was hit by a regulatory probe back home within days of its 2021 float in New York, the 129 Chinese and Hong Kong companies that have gone public stateside have been minnows, raising an average $35mn apiece."}],[{"start":135.04,"text":"That leaves Hong Kong competing most fiercely against Shanghai — which is currently basking in the riotous debut of memory-chip maker CXMT — and Shenzhen. In mainland China, IPO filings are still public from the get-go, but companies can’t easily go elsewhere without approval from the Chinese government, as Shein’s long wait to go public shows. All of which makes Hong Kong’s efforts look more like a gesture of global competitiveness than the real thing."}],[{"start":168.92,"text":""}]],"url":"https://audio.ftcn.net.cn/album/a_1785307868_6894.mp3"}

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

美债收益率冲击下,欧洲必须自寻出路

埃里安:欧洲不能只盼着大西洋彼岸的借贷成本回落,它必须着手解决自身问题。

AI与通胀:央行行长该担忧到什么程度?

凯恩斯:这取决于一个价值万亿美元问题的答案:AI是否真能带来预期的生产力提升?

印度企业界的乐观情绪站得住脚吗?

印度企业界公开表达的乐观情绪,与家庭和投资者的焦虑情绪之间的落差日益明显。

Lex专栏:中国药企在药品开发领域获得一席之地

外国制药集团如今开始购买中国本土开发创新药物的授权。

特斯拉与太空探索技术公司:以马斯克为中心的庞大企业星系

埃隆•马斯克旗下上市公司的合并有一定道理,但其他股东最终可能不如现在有影响力。

火箭、机器人和风险:马斯克的3.6万亿美元豪赌

全球首富试图促成迄今最大胆的一笔合并交易,但他还需要说服股东和全球监管机构。
设置字号×
最小
较小
默认
较大
最大
分享×